






Europe's biggest drugs company, GlaxoSmithkline, has announced a rise in profits and sales for the third quarter.The company says it has benefitted from moving away from "white pills and western markets" - but it will also see anti-virals and swine flu vaccine further boosting its earnings by the end of the year.Brian Milligan reports.
Tags:. .gsk. .quarterthe. .glaxosmithkline. .milligan. .swine











